Insmed | Tillgångar



Assets Ändra Datum
BioMarin Pharmaceutical USD 6.99B 137.74M 2024-12
Cytokinetics USD 1.4B 34.39M 2024-12
DBV Technologies USD 65.7M 27.36M 2024-12
Dynavax Technologies USD 986.26M 75.73M 2024-12
Gilead Sciences USD 59B 4.47B 2024-12
Insmed USD 2.03B 27.74M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Regeneron Pharmaceuticals USD 37.76B 317.5M 2024-12
Sarepta Therapeutics USD 3.96B 363.24M 2024-12
Ultragenyx Pharmaceutical USD 1.5B 34.91M 2024-12
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



Insmed Tillgångar - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.